56 related articles for article (PubMed ID: 30606477)
21. lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling.
Tang T; Wang LX; Yang ML; Zhang RM
Mol Med Rep; 2020 Dec; 22(6):4857-4867. PubMed ID: 33173989
[TBL] [Abstract][Full Text] [Related]
22. AHIF promotes glioblastoma progression and radioresistance via exosomes.
Dai X; Liao K; Zhuang Z; Chen B; Zhou Z; Zhou S; Lin G; Zhang F; Lin Y; Miao Y; Li Z; Huang R; Qiu Y; Lin R
Int J Oncol; 2019 Jan; 54(1):261-270. PubMed ID: 30387845
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4.
Guo P; Yu Y; Tian Z; Lin Y; Qiu Y; Yao W; Zhang L
Int J Oncol; 2018 Oct; 53(4):1591-1600. PubMed ID: 30066909
[TBL] [Abstract][Full Text] [Related]
24. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
25. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
27. Upregulated AHIF-mediated radioresistance in glioblastoma.
Liao K; Ma X; Chen B; Lu X; Hu Y; Lin Y; Huang R; Qiu Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):617-623. PubMed ID: 30606477
[TBL] [Abstract][Full Text] [Related]
28. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
29. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
[TBL] [Abstract][Full Text] [Related]
31. The Role of Long Noncoding Ribonucleic Acids in Glioblastoma: What the Neurosurgeon Should Know.
Villa GR; Chiocca EA
Neurosurgery; 2023 Jun; 92(6):1104-1111. PubMed ID: 36880757
[TBL] [Abstract][Full Text] [Related]
32. Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform.
Ghaemi S; Fekrirad Z; Zamani N; Rahmani R; Arefian E
J Drug Target; 2022 Jul; 30(6):589-602. PubMed ID: 35282758
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.
Stackhouse CT; Gillespie GY; Willey CD
Cells; 2020 Oct; 9(11):. PubMed ID: 33126510
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
